Boston Scientific (BSX) Q1 Earnings Beat Estimates, View Raised
https://www.zacks.com/stock/news/2261543/boston-scientific-bsx-q1-earnings-beat-estimates-view-raised?cid=CS-ZC-FT-analyst_blog|earnings_article-2261543
Apr 24, 2024 - Barring Neuromodulation, organic and operational revenues at Boston Scientific's (BSX) core business segments rise in the first quarter.
0
What's in Store for These 4 Medical Products Stocks in Q1 Earnings?
https://www.zacks.com/stock/news/2260506/what-s-in-store-for-these-4-medical-products-stocks-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2260506
Apr 23, 2024 - Medical Products companies' quarterly results are likely to reflect a year-over-year decline in earnings. Let's see how BSX, TMO, ALGN and ICLR fare this time.
0
Unveiling Boston Scientific (BSX) Q1 Outlook: Wall Street Estimates for Key Metrics
https://www.zacks.com/stock/news/2258362/unveiling-boston-scientific-bsx-q1-outlook-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2258362
Apr 19, 2024 - Beyond analysts' top -and-bottom-line estimates for Boston Scientific (BSX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
0
What's in Store for Boston Scientific (BSX) in Q1 Earnings?
https://www.zacks.com/stock/news/2256177/what-s-in-store-for-boston-scientific-bsx-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2256177
Apr 16, 2024 - Boston Scientific (BSX) is expected to have registered strong growth in the Asia Pacific, led by strength in China, Japan and Latin America.
0
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
https://seekingalpha.com/news/4089446-needham-sees-bsx-cnmd-rmd-beating-street-despite-medtech-slow-down?source=feed_sector_healthcare
Apr 14, 2024 - Needham estimates Q1 medtech sales grew less than expected, but that Boston Scientific, CONMED, ResMed and Surmodics should still be able to beat the Street. Read more here.
0
Abbott (ABT) Expands in Canada With First Eterna SCS Use
https://www.zacks.com/stock/news/2245409/abbott-abt-expands-in-canada-with-first-eterna-scs-use?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2245409
Mar 25, 2024 - Abbott's (ABT) Eterna SCS system reduces pain without causing discomfort. It leverages the BurstDR stimulation technology.
0
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
https://www.zacks.com/stock/news/2240665/are-you-a-growth-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2240665
Mar 14, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
Boston Scientific (BSX) Grows IC Business With New FDA Nod
https://www.zacks.com/stock/news/2235447/boston-scientific-bsx-grows-ic-business-with-new-fda-nod?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2235447
Mar 04, 2024 - The AGENT DCB of Boston Scientific (BSX) is already available in Europe, parts of Asia Pacific and Latin America.
0
Why Boston Scientific (BSX) is a Top Momentum Stock for the Long-Term
https://www.zacks.com/stock/news/2234656/why-boston-scientific-bsx-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2234656
Mar 01, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
0
Here's Why You Should Invest in Boston Scientific (BSX) Now
https://www.zacks.com/stock/news/2223513/here-s-why-you-should-invest-in-boston-scientific-bsx-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2223513
Feb 08, 2024 - Investors are optimistic about Boston Scientific (BSX) on strength across the target market and upbeat guidance.
0
Page 1>